KidneyIntelX in Multi-Center Study to Monitor and Predict Kidney Risk in COVID-19 Patients
Surge in Chronic Kidney Disease and Kidney Failure Expected Post-COVID-19Mount Sinai-Led Study to Assess 4,000 Surviving COVID-19 PatientsNEW YORK, Aug. […]
IES Holdings, Inc. Appoints Jeffrey Gendell as Interim Chief Executive Officer
HOUSTON, Aug. 03, 2020 (GLOBE NEWSWIRE) — IES Holdings, Inc. (or “IES” or the “Company”) (NASDAQ: IESC) announced today that […]
Aditx Therapeutics Appoints Jeff Ramson, Wall Street Veteran and Founder of PCG Advisory as Senior Advisor, Capital Markets & Communications
LOMA LINDA, CA, Aug. 03, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), […]
Metastatic Lung Cancer Study Finds That Bionano’s Saphyr Outperforms NGS for the Detection of Structural Variants
SAN DIEGO, Aug. 03, 2020 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO), today announced the publication of the first […]
Top Tech Companies Join Forces to Push for Diversity and Inclusion at Vendor Organizations
SAN MATEO, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) — Today SurveyMonkey announced that 23andMe, Age of Learning (creator of ABCmouse), […]
ATIF Holdings Limited Signs Multimedia Services Contracts with China and Global Top 500 Companies
Shenzhen, China, Aug. 03, 2020 (GLOBE NEWSWIRE) — ATIF Holdings Limited (Nasdaq: ATIF, the “Company”), a company providing business consulting […]
Advaxis Announces Common Stock Purchase Agreement for up to $20 Million with Lincoln Park Capital
PRINCETON, N.J., Aug. 03, 2020 (GLOBE NEWSWIRE) — Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development […]
Melinta Therapeutics Announces Appointment of Christine Ann Miller as President and Chief Executive Officer
MORRISTOWN, N.J., Aug. 03, 2020 (GLOBE NEWSWIRE) — Melinta Therapeutics, Inc. (“Melinta”), a commercial-stage company focused on the development and […]
Aileron Therapeutics Announces Completion of Enrollment in Dose Optimization Expansion Cohort of Proof-of-Concept Phase 1b Study of ALRN-6924
Study is evaluating ALRN-6924 to protect against chemotherapy-induced bone marrow toxicities in patients with p53-mutated small cell lung cancer (SCLC) […]
DZS Names Charlie Vogt President and CEO
PLANO, Texas, Aug. 03, 2020 (GLOBE NEWSWIRE) — DASAN Zhone Solutions, Inc. (NSDQ: DZSI or “DZS”), a leading enabler of […]
